Copyright: ©Author(s) 2026.
World J Psychiatry. Apr 19, 2026; 16(4): 113329
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.113329
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.113329
Table 3 Adverse pregnancy outcomes in postpartum depression group vs controls, n (%)
| Indicators | PPD group (n = 83) | Control group (n = 80) | χ2 | P value |
| PROM | 6 (7.23) | 1 (1.25) | ||
| Preterm birth | 5 (6.02) | 2 (2.50) | ||
| Postpartum hemorrhage | 4 (4.82) | 1 (1.25) | ||
| LGA infants | 3 (3.61) | 0 (0.00) | ||
| HDP | 3 (3.61) | 1 (1.25) | ||
| GDM | 2 (2.41) | 1 (1.25) | ||
| Total | 23 (27.71) | 6 (7.50) | 11.380 | < 0.001 |
- Citation: Chen JJ, Chen XJ, She QM, Ouyang S. Maternal thyroid-stimulating hormone and thyroid peroxidase antibody levels: Associations with postpartum depression and impacts on adverse pregnancy outcomes. World J Psychiatry 2026; 16(4): 113329
- URL: https://www.wjgnet.com/2220-3206/full/v16/i4/113329.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i4.113329